SLC12A2 and cancer: Since the NKCC1 mutation has a prominently prognostic value on pan-cancer patients, we further analyzed the KCC2 (SLC12A5) and NKCC1 (SLC12A2) mutation, and we then queried 48,834 samples in 188 studies for a comprehensive analysis.